Table: Takara Bio -Q1 group results
Aug 8 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2025 Jun 30, 2024 Mar 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 9.27 8.49 52.50
(+9.1 pct) (-7.4 pct) (+16.6 pct)
Operating loss 1.80 loss 1.63 2.50
(+10.5 pct)
Recurring loss 1.84 loss 1.50 2.50
(-3.6 pct)
Net loss 1.51 loss 1.05 1.30
(+24.8 pct)
EPS loss 12.55 yen loss 8.70 yen 10.08 yen
Ann Div 17.00 yen 17.00 yen
-Q2 div NIL NIL
-Q4 div 17.00 yen 17.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T